Loading clinical trials...
Loading clinical trials...
Assessment of Macrophage activation syndrome in STill's disease: retrospective chart analysis of patient History, Symptom resolution and Treatment characteristics
Keep your clinical trial research organized — questions to ask, what to expect, and key details.
Lead Sponsor
Swedish Orphan Biovitrum
NCT05927454 · Still Disease, Still's Disease, Adult-Onset, and more
NCT05814159 · Still's Disease, Juvenile Onset, Still's Disease, Adult-Onset
NCT05715736 · Still's Disease, Adult-Onset
NCT03311854 · Macrophage Activation Syndrome, Lymphohistiocytosis, Hemophagocytic, and more
NCT03332225 · Sepsis, Macrophage Activation Syndrome
Swedish Orphan Biovitrum Research Site
Los Angeles, California
Swedish Orphan Biovitrum Research Site
Atlanta, Georgia
Swedish Orphan Biovitrum Research Site
Cincinnati, Ohio
Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.
Start free trial →Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions